Immunovant Inc (IMVT)

R&D Expense Growth

0.24%

Quarterly · Period ending:

IMVT logo

IMVT R&D Expense Growth

Latest reported0.24%
IMVT Quarterly R&D Growth (QoQ) (0.00% → 0.24%)
High-resolution chart · PNG

IMVT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunovant Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
0.2418%
43.8347%
-13.4137%
12.8943%
8.0608%
-0.9194%
-2.8292%
28.8832%
14.2561%
36.6544%
0.7903%
-5.1725%
-2.4346%
22.6853%
11.9585%
32.7483%
-11.1205%
7.4943%
39.3006%
14.1994%
0.4835%
-11.7396%
76.1106%
-29.2282%
19.4382%
186.0489%
-52.0569%
-44.0842%
131.8326%
3.7249%
33.7425%
32.5161%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.